Retirement Group’s Actinium Pharmaceuticals ATNM Stock Holding History

Retirement Group’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$9.33K	Hold	1,191	–	–	﹤0.01%	482
2023 Q4	$6.05K	Hold	1,191	–	–	﹤0.01%	507
2023 Q3	$7.05K	Hold	1,191	–	–	﹤0.01%	449
2023 Q2	$8.84K	Hold	1,191	–	–	﹤0.01%	429
2023 Q1	$11K	Buy	+1,191	New	+$12.6K	0.01%	382
2022 Q4	–	Sell	-79	Closed	-$1K	–	635
2022 Q3	$1K	Sell	79 -1,050	-93%	-$6.53K	﹤0.01%	428
2022 Q2	$15K	Hold	1,129	–	–	0.01%	369
2022 Q1	$15K	Hold	1,129	–	–	0.01%	383
2021 Q4	$17K	Hold	1,129	–	–	0.01%	355
2021 Q3	$15K	Buy	1,129 +1,050	+1,329%	+$7.3K	0.01%	338
2021 Q2	$1K	Hold	79	–	–	﹤0.01%	595
2021 Q1	$1K	Hold	79	–	–	﹤0.01%	663
2020 Q4	$0	Hold	79	–	–	﹤0.01%	648
2020 Q3	$1K	Hold	79	–	–	﹤0.01%	586
2020 Q2	$1K	Buy	+79	New	+$598	﹤0.01%	570
2019 Q4	$1K	Buy	+79	New	+$545	﹤0.01%	571

Other funds holding ATNM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Retirement Group's ATNM Position: Q1 2024 in Review

Retirement Group held its Actinium Pharmaceuticals (ATNM) position steady in Q1 2024 at 1,191 shares worth $9.33K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

Retirement Group first reported a position in ATNM in Q4 2019 and has held it in 16 quarters since. The position peaked at $17K in Q4 2021. 67 funds tracked by Wall St. Rank hold ATNM as of Q1 2024.

Retirement Group held 1,191 shares of Actinium Pharmaceuticals worth $9.33K as of Q1 2024.
Retirement Group left its Actinium Pharmaceuticals share count unchanged in Q1 2024.
Actinium Pharmaceuticals made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #482 holding.
Retirement Group first reported a position in Actinium Pharmaceuticals in Q4 2019 and has held it in 16 quarters since.
Retirement Group's Actinium Pharmaceuticals position peaked at $17K in Q4 2021.
67 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.